Clinical Medicine and Diagnostics

p-ISSN: 2163-1433     e-ISSN: 2163-1441

2011;  1(1): 1-7

doi: 10.5923/j.cmd.20110101.01

Central Sensitization: Clinical Implications for Chronic Head and Neck Pain

Copyright © 2011 Scientific & Academic Publishing. All Rights Reserved.

Abstract

Chronic clinical pain associated with CS, is a potentially progressive, devastating, multimodal disease with a significant worldwide economic and social burden. Effective intervention is dependent upon recognizing the fundamental differences in acute and chronic pain, the effects on and by the neuromatrix upon the biopsychosocial health of the individual patient, and integrating that knowledge into a comprehensive multidisciplinary therapeutic plan.

Keywords: Chronic Pain, Sensitization, Neuromatrix, Biopsychosocial, Polypharmacy

Paper's body in HTML will come soon.

Reference

[1]  Woolf CJ, ed. Central Sensitization. Pain and the Control of Pain: Pain transmission, regulation and management, , ed. B. A.2009, The Biomedical & Life Sciences Collection, Henry Stewart Talks Ltd, : London
[2]  Wallace DJ, Clauw DJ, ed. Fibromyalgia and Other Central Pain Syndromes. 2005, Lippincott Williams & Wilkins: Philidelphia
[3]  Yunus MB, Inanici F, Clinical characteristics and biopathophysiological mechanisms of fibromyalgia syndrome, in Myofascial pain and fibromyalgia syndromes: a clinical guide to diagnosis and management, Baldry P, Editor 2001, Churchill Livingstone: Edinburgh
[4]  Mense S, Pathophysiology of low back pain and the transition to the chronic state - experimental data and new concepts. Schmerz, 2001. 15(6): p. 413-417
[5]  Melzack R, Pain and the neuromatrix in the brain. J Dent Educ, 2001. 65(12): p. 1378-1382
[6]  May A, Jurgens TP, Therapeutic neuromodulation in primary headaches. Nervenarzt, 2010. Oct 24 Epub ahead of print
[7]  Graven-Nielsen T, Arendt-Nielsen L, Assessment of mechanisms in localized and widespread musculoskeletal pain. Nat Rev Rheumatol, 2010
[8]  Goadsby PJ, Cohen AS, Matharu MS, Trigeminal autonomic cephalgias: diagnosis and treatment. Curr Neurol Neurosci Rep, 2007. 7(2): p. 117-125
[9]  Wei F, Dubner R, Zou S, Ren K, Bai G, Wei D, Guo W, Molecular depletion of descending serotonin unmasks its novel facilitory role in the development of persistent pain. J Neurosci, 2010. 30(25): p. 8624-8636
[10]  Zhuo M, Sengupta JN, Gebhart GF, Biphasic modulation of spinal visceral nociceptive transmission from the rostroventral medial medulla in the rat. J Neurophysiol, 2002. 87: p. 2225-2236
[11]  Wulf-Johansson H, Amrutkar DV, Hay-Schmodt A, Poulsen AN, Klaerke DA, Olesen J, Jansen-Oleson I, Localization of large conductor calcium-activated potassium channels and their effect on calcitonin gene-related peptide release in the rat trigemino-neuronal pathway. Neuroscience, 2010. 167(4): p. 1091-1102
[12]  Thalakoti S, Patil VV, Damodaram S, Vause CV, Langford LE, Freeman SE, Durham PL, Neuron--glia signaling in trigeminal ganglion: implications for migraine pathology. Headache, 2008. 47(7): p. 1008-1023
[13]  Nijs J, Meeus M, OsterwijckJV, Roussel N, De Kooning M, Ickmans K, Matic M, Treatment of central sensitization in patients with 'unexplained' chronic pain: what options do we have? Expert Opin Pharmacother, 2011. Epub ahead of print
[14]  Meeus M, Nijs J, Central sensitization: a biopsychosocial explanation for chronic widespresd pain in patients with fibromyalgia and chronic fatigue syndrome. Clinic Rheum, 2007. 26(4): p. 465-473
[15]  Bendtsen L, Central sensitization in tension-type headache: possible pathophysiological mechanisms. Cephalgia, 2000. 20(5): p. 486-508
[16]  Bolay H, Reuter U, Dunn AK, Huang Z, Boas DA, Moskowitz MA, Intrinsic brain activity triggers trigeminal meningeal afferents in a migraine model. Nat Med, 2002. 8(2): p. 136-142.
[17]  Dodick D, Silberstein S, Central sensitization theory of migraine: clinical implications. Headache, 2006. 46 Suppl 4: p. S182-191
[18]  Graven-Nielsen T, Mense S, The peripheral apparatus of pain: evidence from animal and human studies. Clin J pain, 2001. 17(1): p. 2-10
[19]  Dickinson BD, Head CA, Gitlow S, Osbahr AJ, Maldynia: Pathophysiology and management of neuropathic and maladaptive pain-A report of the AMA council on science and public health. Pain Med, 2010. 11: p. 1635-1653
[20]  Dorr AE, Debonnel G, Effect of vagus nerve stimulation on serotonergic and noradrenergic transmission. J Pharmcol Exp Ther, 2006. 318(2): p. 890-896
[21]  Schlaepfer TE, Frick C, Zobel A, et al, Vagus nerve stimulation for depression: efficacy and safety in a European study. Psychol Med, 2008. 38(5): p. 651-661.
[22]  Zhang Y, Popovic ZB, Bibevesky S, et al, Chronic vagus stimulation improves autonomic control and attenuates systemic inflammation and heart failure progression in a canine high-rate pacing model. Circ Heart Fail, 2009. 2(6): p. 692-699
[23]  Multon S, Schoenen J, Pain control by vagus nerve stimulation: from animal to man.. and back Acta neurol belg, 2005(105): p. 62-67
[24]  La Marca R, Nedeljkovic M, Yuan L, Maercker A, Ehlert U, Effects of auricular electrostimulation on vagal activity in healthy men: evidence from a three armed randomized trial. Clin Sci, 2010. 118: p. 537-546.
[25]  George MS, N.Z., Borckardt JJ, Anderson B, Foust MJ, Burns C, Kose S, Short EB, Vagus nerve stimulation for the treatment of depression and other neuropsychiatric disorders. Exp Rev Neurotherapeutics, 2007. 7(1): p. 1-12
[26]  Miraucourt LS, Moisset X, Dallel R, Voisin DL, Glycine inhibitory dysfunction induces a selectively dynamic, morhine-resistant, and neurokinin 1 receptor-independent mechanical allodynia. J Neurosci, 2009. 29(8): p. 2519-2527
[27]  Levy D, Jakubowski M, Burstein R, Disruption of communication between peripheral and central trigeminovascular neurons mediates the antimigraine action of 5HT 1B/1D recerptor agonists. Proc Natl Acad Sci USA, 2004. 23(101): p. 4274-7279
[28]  Goadsby PJ, Neurostimulation in primary headache syndromes. Exp Rev Neurotherapeutics, 2007. 7(12): p. 1785-1789
[29]  Edvinsson L, Ho TW, CGRP receptor antagonism and migraine. Neurotherapeutics, 2010. 7(2): p. 164-175
[30]  Ebersberger A, Pathophysiology of migraine: models to explain the generation of migraine headache. Anaesthetist, 2002. 51(8): p. 661-667
[31]  Benemei S, Nicoletti P, Capone JG, Geppetti P, CGRP receptors in the control of pain and inflammation. Curr Opin Pharmacol, 2009. 9(1): p. 9-14
[32]  Ackerman S, Holland PR, Lasalanda MP. Goadsby PJ, Inhibition trigeminovascular dural nociceptive afferents by Ca(2+)-activated K(+) (MaxiK/BK(Ca) channel opening. Pain, 2010. 151(1): p. 128-136.
[33]  Silverman M, Heim CM, Nater UM, Marques AH, Sternberg EM, Neuroendocrine and immune contributors to fatigue. PM R, 2010. 2(5): p. 338-346
[34]  Ji RR, S.G., Cell signaling and the genesis of neuropathic pain. Sci STKE, 2004(252): p. 1 4
[35]  Watkins LR, H.M., Ledeboer A, Wiesler-Frank J, Milligan ED, Maier SF, Glia as the "bad guys": implications for improving clinical pain control and the clinical utility of opioids. Brain Behav Immun, 2007. 21(2): p. 131 -146
[36]  Watkins LR, H.M., Rice KC, Maier SF, the "toll" opioid-induced glial activation: improving the clinical efficacy of opioids by targeting glia. Trends Pharmacol Sci, 2009. 30(11): p. 581-591
[37]  Watkins LR, M.E., Maier SF, Glial proinflammatory cytokines mediate exaggerated pain states: implications for clinical pain. Adv Exp Med Biol, 2003(521): p. 1-21
[38]  Watkins LR, M.S., The pain of being sick: implications of immune to brain communication for understanding pain. Ann Rev Psychol, 2000. 51: p. 29-57
[39]  Turk DC, A diathesis-stress model of chronic pain and disability following traumatic injury. Pain, 2002. Research And Management (7): p. 8-19
[40]  Dufour N, Thamsborg G Oefeldt A Lundsgaard C Stender S, Treatment of Chronic Low Back Pain: A Randomized, Clinical Trial Comparing Group-Based Multidisciplinary Biopsychosocial Rehabilitation and Intensive Individual Therapist-Assisted Back Muscle Strengthening Exercises. Spine, 2010
[41]  Fitzcharles MA, Lussier D, Shir Y, Management of chronic arthritis pain in the elderly. Drugs Aging, 2010. 27(6): p. 471-490
[42]  Goldenberg DL, Pharmacological treatment of fibromyalgia and other chronic musculoskeletal pain. Best Pract Res Clin Rheumatol, 2007. 21: p. 499-511
[43]  Millan MJ, Descending control of pain. Prog Neurobiol, 2002. 66: p. 355-374
[44]  Portenoy RK, Current pharmacotherapy of chronic pain. J Pain Sympt Manag, 2000. 19(Suppl): p. 16-20
[45]  Yamada K, Moriwaki K, Oiso H, Ishigooka J, High prevalence of comorbidity of migraine in outpatients with panic disorder and effectiveness of psychopharmacotherapy for both disorders: a retrospective study Psyychiatry Res, 2010. May 21 (Epub ahead of print)
[46]  Smith HS, Potential analgesic mechanisms of acetaminophen. Pain Physician, 2009. 12(1): p. 269-280
[47]  Suarez-Roca H, Leal L, Silva JA, et al, Reduced Neurotransmission underlies hyperalgesia induced by repeated forced swimming stress Behav Brain Res, 2008. 189: p. 159-169
[48]  Quintero L, Montero M, Avila C, et al, Long-lasting delayed hyperalgesia afterr subchronic swimm stress. Pharmacol Biochem Behav, 2000. 67: p. 449-458
[49]  Samad TA, Moore KA, Sapirstein A, et al, Interleukin-1 beta mediated induction of COX-2 in the CNS contributes to inflammatory pain hypersensitivity. Nature, 2001. 410: p. 471-475
[50]  Bazan NG, COX-2 as a multifunctional neuronal modulator. Nat Med, 2001. 7: p. 414-415
[51]  Watkins LR, Maier SF, Implications of immune-to-brain communication for sickness and pain. Proc Natl Acad Sci USA, 1999. 96: p. 7710-7713
[52]  Crofford LJ, Adverse effects of chronic opioid therapy for chronic musculoskeletal pain. Nat Rev Rheumatol, 2010. 6: p. 191-197
[53]  Sang CN, NMDA-receptors antagonists in neuropathic pain: Experimental methods to clinical trials. J Pain Symptom Manage, 2000. 19(Suppl): p. 21-25
[54]  Chiechio S, Zammataro M, Caraci F, et al, Pregabalin in the treatment of chronic pain: An overview. Clin Drug Investig, 2009. 29: p. 203-213
[55]  Vanderah TW, Ossipov MH, Lai J, et al, Descending facilitation and spinal dynorphin. Pain, 2001. 92: p. 5-9
[56]  Leo RJ, Latif T, Repetitive transcranial magnetic stimulation (rTMS) in experimentally induced and chronic neuropathic pain: a review. J Pain, 2007. 8: p. 453-459
[57]  Lefaucheur JP, The use of repetitive transcranial magnetic stimulation (rTMS) in chronic neuropathic pain. Clin Neurophysiol, 2006. 36: p. 117-124
[58]  Nahmias F, Debes C, Ciampi de Andrade D, et al, Diffuse analgesic effects of unilateral repetitive transcranial magnetic stimulation (rTMS) in healthy volunteers. Pain, 2009. 147: p. 224-232.
[59]  Ji R-R, Kohno T, Moore KA, Woolf CJ, Central sensitization and LTP: do pain and memory share similar mechanisms? Trends in Neurosci, 2001. 26(12): p. 696-705
[60]  Sterling M, Pedler A, Chan C, et al, Cervical lateral glide increases nociceptive flexion reflex threshold but not pressure or thermal pain thresholds in chronic whiplash associated disorders: a pilot randomised controlled trial. Man Ther, 2009. 15(2): p. 149-153
[61]  Stanton-Hicks M, Baron R, Boas R, Gordh T, Harden N, Hendler N, Koltzenburg M, Raj P, Wilder R, Complex Regional Pain Syndromes: Guidelines for Therapy (Consensus Report). Clin J Pain, 1998. 14(2): p. 155-166
[62]  Flor, H.H., C., Psychosocial Aspects of Pain: A Handbook for Health Care Providers,. Progress in Pain Research and Management. Vol. 27. 2004, Seattle WA: IASP
[63]  Turk DC, Flor H, Chronic pain: a biobehavaioral perrspective, in Psychosocial factors in pain: critical perspectives, Gatchel RJ, Turk DC, Editor 1999, Guilford Publications: New York. p. 18-34
[64]  Thacker M, M.G., Flor H., Neuropathic pain. Management is more than pills. BMJ, 2009. 339(1)
[65]  Shahrbanian S, Ma X, Korner-Bitensky N, Simmonds MJ, Scientific evidence for the effectiveness of virtual reality for pain reduction in adults with acute or chronic pain. Stud Health Technol Inform, 2009. 144: p. 40-43
[66]  !!! INVALID CITATION !!!
[67]  DeLeo, J.A., Basic Science of Pain. J Bone Joint Surg Am, 2006. 88(suppl_2): p. 58-62
[68]  Wang H, Guo W, Yang K, Wei F, Dubner R Ren K, Contribution of primary afferent input to trigeminal astroglial hyperactivity, cytokine induction and NMDA receptor phosporylation. Open Pain J, 2010. 3: p. 144-152
[69]  Wright A, Sluka KA, Nonpharmacological treatments for musculoskeletal pain. Clin J Pain, 2001. 17: p. 43-46
[70]  Weiner DK, Ernst E, Complementary and alternative approaches to the treatment of persistent musculoskeletal pain. Clin J Pain, 2004. 20: p. 244-255
[71]  Sauer K, Kemper C, Glaeske G, Fibromyalgia syndrome: Prevalence, pharmacological and non-pharmacological interventions in outpatient healthcare. an analysis of statutory health insurance data. Joint Bone Spine, 2011. 78(1): p. 80-84
[72]  Ghoname EA, C.W., White PF, Ahmed HE, Hamza MA, Noe CE, Percutaneous electrical nerve stimulation: an alternative to TENS in the management of sciatica. Pain, 1999. 83: p. 193-199
[73]  Branfort G, Nilsson N, Haas M, Evvans RL, Goldsmith CH, Assendelft WJJ, Bouter LM, Non-invasive physical treatments for chronic/recurrent headache (review). Cochrane Library, 2009(1)
[74]  Fishman SM, Ballantyne JC, Rathwell JP, ed. Bonica's Management of Pain. 4 ed. 2009, Lippincott Williams & Wilkins: Philadelphia